ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295500 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295500; 2) Community: the network communities that were significantly associated with the response to NSC 295500; 3) Molecule: the relationships between components within communities and NSC 295500; 4) MDR: the compounds that were significantly associated with the NSC 295500.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.00824865245912294 0.81260494
NSC 683556 Camptothecin Derivative 0.00824865245912294 0.757916
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.00824865245912294 0.17241693
NSC 700363 Liposomal Annamycin 0.00824865245912294 0.69738385
NSC 715974 Null 0.00824865245912294 0.30720478
NSC 726364 Null 0.00824865245912294 0.28562907
NSC 759878 Irinotecan hydrochloride (USAN) 0.00824865245912294 0.79176259
NSC 329127 Null 0.00921214104936179 -0.11442572
NSC 37186 Null 0.00921214104936179 0.10554001
NSC 619321 Null 0.00921214104936179 0.34107491
Total:54  Current:8    [First] [Prev] [Next] [Last]